• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS); VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS); VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 106016
Device Problems Decreased Pump Speed (1500); Infusion or Flow Problem (2964)
Patient Problems No Consequences Or Impact To Patient (2199); No Code Available (3191)
Event Date 10/08/2020
Event Type  malfunction  
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is completed.
 
Event Description
It was reported that the patient came to the hospital and reported about (red heart) alarms on their controller when connected to the ppm.The alarms did not appear on battery support.Log file analysis confirmed the alarms and showed periods where the pump was not able to keep the set speed when connected to the ppm.X-ray scans showed an unremarkable driveline.The patient was asymptomatic and admitted to the hospital.The patient received a pump exchange to heartmate 3 on (b)(6) 2020.
 
Manufacturer Narrative
Section d7, h4, h6 (patient code): correction.Section d10, h3: additional information.Manufacturer's investigation conclusion: the evaluation of heartmate ii lvas, serial number (b)(6), identified an internal driveline issue that could have contributed to the report of the pump not being able to maintain the set speed while connected to the power module, which was confirmed through the evaluation of the submitted system controller log file.The submitted log file captured several transient pump stops and low speed hazard events from 21:39:35 through 21:52:29 on (b)(6) 2020 while at least one system controller power cable was connected to a power module.Power elevations up to 19.7 w were observed during some of these events, and low flow hazard events were noted at times when a low speed hazard was active by design.It was reported that the patient underwent a pump exchange to a heartmate 3 on (b)(6)2020.(b)(6) was returned assembled with the driveline severed approximately 6¿ from the pump housing.The distal end of the driveline was returned in a segment measuring approximately 32¿, and the remainder of the driveline was not returned.Internal metal braided shield breakdown was observed approximately 9.5¿ through 10.5¿ from the pump housing.Electrical continuity testing of the driveline revealed that a short to shield was able to be induced in the yellow wire upon manipulation of the driveline at the location of the observed metal braided shield breakdown.Visual inspection of the underlying wires of the driveline revealed a breach in the insulation of the yellow wire approximately 9.5¿ from the pump housing, exposing the inner conductors.This damage appears consistent with fatigue failure due to repetitive flexing and abrasion against the metal braided shield.If the exposed inner conductors of the yellow wire made contact with the metal braided shield while the system controller was tethered to a grounded power source such as the power module, the resulting electrical short to ground could have resulted in the pump stops and low speed events observed in the submitted log file.Incidental findings: upon disassembly of the motor capsule from the outlet housing, a significant amount of silicone material appeared to have been removed from the motor capsule and adhered to the interior of the outlet housing.An exact duration that the silicone was adhered to the outlet housing and a specific cause for this finding could not be conclusively established through this evaluation.The silicone encapsulation issue did not appear to have affected device functionality.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The implant kit was shipped on (b)(6)2018.The heartmate ii lvas patient handbook contains a section on ¿caring for the driveline¿; however, all heartmate ii lvad drivelines have the potential for wire/shield breakdown to occur dependent upon length of use and patient handling.Section 5 entitled ¿alarms and troubleshooting¿ outlines all system controller alarms and provides information regarding how to respond to and troubleshoot the alarms.Heartmate ii lvas ifu section 6 entitled ¿patient care and management¿ outline indications of driveline damage as well as how to respond to such events.Section 7 entitled ¿alarms and troubleshooting¿ outlines all system controller alarms, including the low flow hazard alarm, and provides information regarding how to respond to and troubleshoot the alarms.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS)
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
MDR Report Key10719336
MDR Text Key212538424
Report Number2916596-2020-05134
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024011231
UDI-Public(01)00813024011231(10)6284888(17)201130
Combination Product (y/n)N
PMA/PMN Number
P060040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 12/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/22/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date11/30/2020
Device Model Number106016
Device Catalogue Number106016
Device Lot Number6284888
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/28/2020
Was the Report Sent to FDA? No
Date Manufacturer Received11/25/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-